Jianyang Du

563 total citations
28 papers, 379 citations indexed

About

Jianyang Du is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Jianyang Du has authored 28 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 11 papers in Pulmonary and Respiratory Medicine and 10 papers in Cancer Research. Recurrent topics in Jianyang Du's work include Ferroptosis and cancer prognosis (8 papers), RNA modifications and cancer (8 papers) and Cancer-related molecular mechanisms research (8 papers). Jianyang Du is often cited by papers focused on Ferroptosis and cancer prognosis (8 papers), RNA modifications and cancer (8 papers) and Cancer-related molecular mechanisms research (8 papers). Jianyang Du collaborates with scholars based in China and United States. Jianyang Du's co-authors include Hang Ji, Shaoshan Hu, Shan Mi, Yuan Li, Shuai Ma, Shuai Ma, Jilong Zou, Jiaqi Jin, Lei Chen and Jiawei Dong and has published in prestigious journals such as Nature Communications, Frontiers in Immunology and Medicine.

In The Last Decade

Jianyang Du

27 papers receiving 377 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jianyang Du China 12 270 179 68 49 46 28 379
Shan Mi China 11 262 1.0× 170 0.9× 75 1.1× 59 1.2× 66 1.4× 15 494
Tse‐Shun Huang United States 11 382 1.4× 247 1.4× 83 1.2× 25 0.5× 40 0.9× 12 525
Haohao Huang China 9 268 1.0× 164 0.9× 36 0.5× 40 0.8× 78 1.7× 11 350
Xuqiang Zhu China 9 211 0.8× 169 0.9× 37 0.5× 25 0.5× 30 0.7× 15 306
Xiaowu Sheng China 10 330 1.2× 157 0.9× 34 0.5× 24 0.5× 33 0.7× 15 464
Lee Chuen Liew Japan 8 248 0.9× 131 0.7× 19 0.3× 30 0.6× 32 0.7× 12 369
Pauline Dmitriev United States 8 177 0.7× 154 0.9× 24 0.4× 21 0.4× 90 2.0× 15 328
Yuanshuai Zhou China 12 256 0.9× 179 1.0× 30 0.4× 14 0.3× 34 0.7× 31 396
Changqing Pan China 10 127 0.5× 85 0.5× 44 0.6× 31 0.6× 82 1.8× 21 289

Countries citing papers authored by Jianyang Du

Since Specialization
Citations

This map shows the geographic impact of Jianyang Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianyang Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianyang Du more than expected).

Fields of papers citing papers by Jianyang Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianyang Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianyang Du. The network helps show where Jianyang Du may publish in the future.

Co-authorship network of co-authors of Jianyang Du

This figure shows the co-authorship network connecting the top 25 collaborators of Jianyang Du. A scholar is included among the top collaborators of Jianyang Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianyang Du. Jianyang Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Fang, Jiawei Dong, Yuyun Xu, et al.. (2024). Turning attention to tumor–host interface and focus on the peritumoral heterogeneity of glioblastoma. Nature Communications. 15(1). 10885–10885. 3 indexed citations
2.
Zhang, Shilin, Jianyang Du, Zhiyou Yang, et al.. (2023). Tilapia Skin Peptides Inhibit Apoptosis, Inflammation, and Oxidative Stress to Improve Dry Eye Disease In Vitro and In Vivo. Journal of Food Biochemistry. 2023. 1–14. 4 indexed citations
3.
Song, Qian, Dongming Zhou, Jianyang Du, et al.. (2023). Andrographis paniculata ameliorates estrogen deficiency-related osteoporosis by directing bone marrow mesenchymal stem cell fate. Annals of Translational Medicine. 11(2). 52–52. 4 indexed citations
4.
Dong, Jiawei, Fang Wang, Xin Gao, et al.. (2023). Integrated analysis of genome-wide DNA methylation and cancer-associated fibroblasts identified prognostic biomarkers and immune checkpoint blockade in lower grade gliomas. Frontiers in Oncology. 12. 977251–977251. 7 indexed citations
5.
Ma, Shuai, et al.. (2022). Inhibition of hypoxia-inducible factor 1 by acriflavine renders glioblastoma sensitive for photodynamic therapy. Journal of Photochemistry and Photobiology B Biology. 234. 112537–112537. 11 indexed citations
6.
Wu, Jiasheng, Jiheng Zhang, Hang Ji, et al.. (2022). Identification of EMT-Related Genes and Prognostic Signature With Significant Implications on Biological Properties and Oncology Treatment of Lower Grade Gliomas. Frontiers in Cell and Developmental Biology. 10. 887693–887693. 4 indexed citations
7.
8.
Ma, Shuai, Fang Wang, Nan Wang, et al.. (2022). Extended Application of Genomic Selection to Screen Multi-Omics Data for the Development of Novel Pyroptosis-Immune Signatures and Predicting Immunotherapy of Glioma. Frontiers in Pharmacology. 13. 893160–893160. 5 indexed citations
9.
Zhang, Jiheng, Nan Wang, Jiasheng Wu, et al.. (2022). 5-Methylcytosine Related LncRNAs Reveal Immune Characteristics, Predict Prognosis and Oncology Treatment Outcome in Lower-Grade Gliomas. Frontiers in Immunology. 13. 844778–844778. 25 indexed citations
10.
Ji, Hang, Hongtao Zhao, Jiaqi Jin, et al.. (2022). Novel Immune-Related Gene-Based Signature Characterizing an Inflamed Microenvironment Predicts Prognosis and Radiotherapy Efficacy in Glioblastoma. Frontiers in Genetics. 12. 736187–736187. 3 indexed citations
11.
12.
Ma, Shuai, et al.. (2021). Recognition of Tumor-Associated Antigens and Immune Subtypes in Glioma for mRNA Vaccine Development. Frontiers in Immunology. 12. 738435–738435. 23 indexed citations
13.
Zou, Jilong, et al.. (2021). Resveratrol benefits the lineage commitment of bone marrow mesenchymal stem cells into osteoblasts via miR‐320c by targeting Runx2. Journal of Tissue Engineering and Regenerative Medicine. 15(4). 347–360. 16 indexed citations
14.
Du, Jianyang, et al.. (2021). Astragaloside IV protects against iron loading‐induced abnormal differentiation of bone marrow mesenchymal stem cells (BMSCs). FEBS Open Bio. 11(4). 1223–1236. 15 indexed citations
15.
16.
Liu, Jie, Jianyang Du, Shan Mi, et al.. (2021). Dihydroartemisinin prompts amplification of photodynamic therapy-induced reactive oxygen species to exhaust Na/H exchanger 1-mediated glioma cells invasion and migration. Journal of Photochemistry and Photobiology B Biology. 219. 112192–112192. 14 indexed citations
17.
Du, Jianyang, et al.. (2020). Pituitary adenoma secondary to primary hypothyroidism. Medicine. 99(8). e19222–e19222. 9 indexed citations
18.
Mi, Shan, Jianyang Du, Jie Liu, et al.. (2020). FtMt promotes glioma tumorigenesis and angiogenesis via lncRNA SNHG1/miR-9-5p axis. Cellular Signalling. 75. 109749–109749. 18 indexed citations
19.
Du, Jianyang, Shan Mi, Li Yuan, et al.. (2020). Identification of Prognostic Model and Biomarkers for Cancer Stem Cell Characteristics in Glioblastoma by Network Analysis of Multi-Omics Data and Stemness Indices. Frontiers in Cell and Developmental Biology. 8. 558961–558961. 33 indexed citations
20.
Yu, Ying, et al.. (2018). Primary Spinal Malignant Mesothelioma: A Case Report and Literature Review. World Neurosurgery. 114. 211–216. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shan Mi Breakdown of academic impact, for papers by Tse‐Shun Huang Breakdown of academic impact, for papers by Haohao Huang Breakdown of academic impact, for papers by Xuqiang Zhu Breakdown of academic impact, for papers by Xiaowu Sheng Breakdown of academic impact, for papers by Lee Chuen Liew Breakdown of academic impact, for papers by Pauline Dmitriev Breakdown of academic impact, for papers by Yuanshuai Zhou Breakdown of academic impact, for papers by Changqing Pan
Rankless by CCL
2026